The Brink's (BCO) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Goldman Sachs | Maintained | Buy | $145.00 from $129.00 | Mar 2, 2026 |
| Truist Securities | Maintained | Buy | $163.00 from $138.00 | Feb 10, 2026 |
| Truist Securities | Maintained | Buy | $138.00 from $144.00 | Nov 7, 2024 |
| Truist Securities | Maintained | Buy | $144.00 from $110.00 | Sep 20, 2024 |
| William Blair | Initiated Coverage | Outperform | — | May 21, 2024 |
| Goldman Sachs | Maintained | Buy | $103.00 from $98.00 | Mar 1, 2024 |
| Truist Securities | Maintained | Buy | $110.00 from $90.00 | Feb 28, 2024 |
| Goldman Sachs | Maintained | Buy | $92.00 from $81.00 | Aug 10, 2023 |
| Truist Securities | Maintained | Buy | $90.00 from $78.00 | Mar 24, 2023 |
Frequently asked questions
Is BCO a buy, sell, or hold?
Analysts covering The Brink's currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on BCO?
On Mar 2, 2026, Goldman Sachs maintained The Brink's at Buy with a price target of $145.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.